Published in Gene Therapy Weekly, November 18th, 1996
Chemotherapy of human cancers often is limited by the increasing resistance of tumor cells in the dose range which can be tolerated by patients. The challenge of cancer therapy has lead researchers to devise new ways of protecting the patient against cytotoxic effects, to develop new therapies, and to sensitize specifically the cancer cells to the cytotoxic effects of current chemotherapeutics.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.